• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday

    8/31/22 5:50:17 AM ET
    $AA
    $ABVC
    $AHI
    $AMST
    Aluminum
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AA alert in real time by email

    Gainers

    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares surged 103.9% to settle at $5.30 on Tuesday. Shares are in low-float territory; the issue has about 15 million shares in its float.
    • NewAge, Inc. (NASDAQ:NBEV) shares jumped 74.2% to close at $0.3632 on Tuesday.
    • IN8bio, Inc. (NASDAQ:INAB) surged 39.4% to settle at $2.76 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02. HC Wainwright & Co. initiated coverage on IN8bio with a Buy rating and announced a price target of $14.
    • TMC the metals company Inc. (NASDAQ:TMC) jumped 33.3% to close at $1.12. The company recently posted a quarterly loss of $0.05 per share.
    • TDH Holdings, Inc. (NASDAQ:PETZ) rose 29.3% to settle at $4.81. The company recently announced it acquired all of the equity interest of Beijing Wenxin Company from Kargo Services.
    • Mercurity Fintech Holding Inc. (NASDAQ:MFH) gained 25.9% to close at $1.02.
    • OKYO Pharma Limited (NASDAQ:OKYO) gained 21.2% to close at $2.4361. OKYO Pharma plans Q4 IND filing of OK-101 to treat dry eye disease with subsequent Phase 2 initiation.
    • Forge Global Holdings, Inc. (NYSE:FRGE) rose 20.9% to close at $4.17.
    • Liquid Media Group Ltd. (NASDAQ:YVR) jumped 17.7% to settle at $0.4723 after the company reported Q2 sales results up year over year.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares gained 17.2% to close at $3.34 after a 13D Filing showed Cincinnati Cornerstone Investors reported a 22.9% stake in the company.
    • American Outdoor Brands, Inc. (NASDAQ:AOUT) jumped 17.1% to close at $9.10 after B. Riley upgraded the stock from Neutral to Buy and announced an $11 price target.
    • ECMOHO Limited (NASDAQ:MOHO) rose 16.7% to settle at $0.1715.
    • DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) jumped 16.7% to close at $10.76.
    • International Game Technology announced an agreement to settle legal proceedings related to Benson V. Double Down Interactive.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) gained 16% to close at $0.9524. ABVC BioPharma recently said Phase II Vitargus clinical trial received Local Ethics Committee approval in Thailand.
    • Hour Loop, Inc. (NASDAQ:HOUR) surged 15.2% to settle at $3.78.
    • Tuesday Morning Corporation (NASDAQ:TUEM) rose 14.5% to close at $0.3666.
    • Mega Matrix Corp. (NYSE:MTMT) gained 14.3% to close at $1.52.
    • Avid Technology, Inc. (NASDAQ:AVID) gained 12.1% to close at $27.04. Avid Technology will replace Plantronics in the S&P SmallCap 600 on Thursday, September 1.
    • Augmedix, Inc. (NASDAQ:AUGX) rose 12.1% to settle at $1.85. Augmedix recently posted Q2 sales of $7.33 million.
    • Big Lots, Inc. (NYSE:BIG) surged 11.7% to close at $24.08 after the company reported a second-quarter FY22 sales decline of 7.6% year-on-year to $1.346 billion, marginally beating the consensus of $1.34 billion. Comparable sales decreased 9.2%.
    • 8x8, Inc. (NYSE:EGHT) fell 11.2% to close at $5.27.
    • American Woodmark Corporation (NASDAQ:AMWD) rose 10.5% to close at $52.44 after reporting better-than-expected Q1 results.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) rose 7.9% to close at $3.54.
    • FaZe Holdings Inc. (NASDAQ:FAZE) rose 7.3% to close at $18.22.
    • Check-Cap Ltd. (NASDAQ:CHEK) gained 6.7% to close at $0.44 after gaining over 4% on Monday.
    • Getty Images Holdings, Inc. (NYSE:GETY) rose 6.4% to settle at $21.43.
    • Xometry, Inc. (NASDAQ:XMTR) gained 5.4% to settle at $51.08.

     

    Losers

    • Amesite Inc. (NASDAQ:AMST) shares tumbled 51.5% to close at $0.4038 on Tuesday after the company announced a $2.3 million registered direct offering.
    • Baudax Bio, Inc. (NASDAQ:BXRX) shares dipped 43.1% to settle at $0.3105 after the company reported pricing of $6.2 million public offering.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) fell 36.9% to close at $0.0990. Clarus Therapeutics shares dipped 23% on Monday after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.
    • Liquidia Corporation (NASDAQ:LQDA) fell 30.4% to close at $5.38.
    • Advanced Human Imaging Limited (NASDAQ:AHI) fell 26.5% to close at $0.97. Advanced Human Imaging shares jumped 94% on Monday after the company announced it signed a Master Services Agreement with Activate Health OÜ.
    • Azure Power Global Limited (NYSE:AZRE) dropped 26.3% to close at $4.31 after Credit Suisse downgraded the stock from Outperform to Underperform and lowered its price target from $22 to $5.
    • The OLB Group, Inc. (NASDAQ:OLB) fell 25% to close at $1.50.
    • Sentage Holdings Inc. (NASDAQ:SNTG) shares fell 24.6% to close at $3.77 on possible profit taking after the stock surged Monday.
    • FiscalNote Holdings, Inc. (NYSE:NOTE) declined 24.4% to settle at $7.46. BTIG initiated coverage on FiscalNote Holdings with a Buy rating and announced a price target of $14.
    • AMTD Digital Inc. (NYSE:HKD) fell 24.2% to close at $105.00. Shares of technology companies traded lower amid overall market weakness as stocks continue to fall following last week's comments from Fed Chair Powell, which indicated the Fed will remain aggressive in its monetary policy stance to fight inflation.
    • Photronics, Inc. (NASDAQ:PLAB) fell 23.6% to close at $16.64. Photronics posted upbeat Q3 results, but issued weak outlook for the current quarter.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) fell 23.1% to close at $2.27.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) fell 22.7% to close at $6.47 on profit-taking after the stock surged following its IPO.
    • Starbox Group Holdings Ltd. (NASDAQ:STBX) declined 21.3% to close at $5.07 as the stock sees volatility following its IPO last Tuesday.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) dropped 21.1% to close at $0.99. Morgan Stanley downgraded Cabaletta Bio from Overweight to Equal-Weight and lowered the price target from $15 to $3.
    • Onfolio Holdings, Inc. (NASDAQ:ONFO) fell 20.5% to close at $1.75. The company recently priced its IPO at $5 per unit.
    • Cross Timbers Royalty Trust (NYSE:CRT) fell 20% to close at $19.70. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Kuke Music Holding Limited (NYSE:KUKE) dropped 18.8% to settle at $0.84.
    • Yiren Digital Ltd. (NYSE:YRD) declined 18.2% to close at $0.7051.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) fell 17.7% to close at $5.43.
    • Winc, Inc. (NYSE:WBEV) dropped 17.4% to close at $1.00. Winc recently posted a Q2 loss of $0.32 per share.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) fell 16.9% to close at $7.60.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) fell 16.5% to close at $0.8350.
    • Jounce Therapeutics, Inc. (NASDAQ:JNCE) fell 15.9% to close at $3.61 after the company reported top line data from Phase 2 SELECT trial evaluating Vopratelimab.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) fell 15% to close at $1.19.
    • Houston American Energy Corp. (NYSE:HUSA) fell 14.7% to close at $4.23.
    • REX American Resources Corporation (NYSE:REX) fell 14.5% to close at $28.75. The company reported upbeat quarterly earnings.
    • UTStarcom Holdings Corp. (NASDAQ:UTSI) dropped 14.4% to settle at $3.38.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) declined 13.6% to close at $0.20. Ladenburg Thalmann recently initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
    • Silver Crest Acquisition Corporation (NASDAQ:SLCR) fell 13.5% to close at $8.78.
    •  
    • BrainsWay Ltd. (NASDAQ:BWAY) fell 13.3% to close at $4.03. The FDA, on Monday, granted 510(k) clearance to BrainsWay’s Deep Transcranial Magnetic Stimulation (TMS) H7 Coil for its use in treating adults suffering from major depressive disorder and depression, including those with comorbid anxiety symptoms commonly known as anxious depression.
    • Veru Inc. (NASDAQ:VERU) fell 9.8% to close at $14.88.
    • iQIYI, Inc. (NASDAQ:IQ) declined 9.7% to close at $3.55 after the company reported Q2 earnings results.
    • Nikola Corporation (NASDAQ:NKLA) fell 9.4% to close at $5.41 after the company filed a prospectus related to the issuance and sale of common stock from time to time up to $400 million. The company also announced an exchange offer to purchase all outstanding shares of Romeo Power.
    • Melco Resorts & Entertainment Limited (NASDAQ:MLCO) fell 9.2% to close at $5.52.
    • Alcoa Corporation (NYSE:AA) dropped 8.5% to close at $50.79. Alcoa to curtail one third of production capacity at Lista Smelter in Norway to mitigate high energy costs.
    • Arch Resources, Inc. (NYSE:ARCH) fell 6.8% to settle at $147.27.
    • Helmerich & Payne, Inc. (NYSE:HP) dropped 6.5% to close at $42.48. Shares of several energy companies traded lower as the sector pulls back from recent gains amid raised concerns of aggressive interest rates hikes, which could pressure oil demand.
    • Baidu, Inc. (NASDAQ:BIDU) declined 6.5% to close at $137.69 after the company reported Q2 EPS results.
    Get the next $AA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AA
    $ABVC
    $AHI
    $AMST

    CompanyDatePrice TargetRatingAnalyst
    Helmerich & Payne Inc.
    $HP
    2/9/2026$35.00 → $38.00Hold
    TD Cowen
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Alcoa Corporation
    $AA
    1/27/2026$64.00Overweight → Equal-Weight
    Morgan Stanley
    Melco Resorts & Entertainment Limited
    $MLCO
    1/16/2026$7.70Overweight → Neutral
    Analyst
    Alcoa Corporation
    $AA
    1/13/2026$71.00Overweight → Equal Weight
    Wells Fargo
    Alcoa Corporation
    $AA
    1/8/2026$50.00Neutral → Underweight
    Analyst
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Helmerich & Payne Inc.
    $HP
    12/18/2025$35.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $AA
    $ABVC
    $AHI
    $AMST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Getty Images and NASCAR Renew Multi-Year Agreement

    A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Getty Images (NYSE:GETY), a preeminent global visual content creator and marketplace, today announced the renewal of its long-standing partnership with NASCAR, extending its role as NASCAR's Official Photography Partner, a designation it has held since 2006. The agreement sees Getty Images' team of specialized motorsport photographers deliver high-quality imagery from all races and events in the NASCAR series, including NASCAR Cup Series™, NASCAR O'Reilly Auto Parts Series™, and NASCAR CRAFTSMAN Truck Series™. With exclusive, behind-the-scenes access, Getty

    2/12/26 8:00:00 AM ET
    $GETY
    Real Estate

    Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2025 Earnings

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE:MSC) ("Studio City" or the "Company"), a world-class integrated resort located in Cotai, Macau, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Total operating revenues for the fourth quarter of 2025 were US$160.3 million, compared with US$152.9 million in the fourth quarter of 2024. The increase was primarily attributable to better performance in mass market table games operations leading to an increase in revenue from casino contract and higher non-gaming revenues. Studio City Casino generated gross gaming revenues of US$342.7 million an

    2/12/26 7:57:37 AM ET
    $MLCO
    $MSC
    Hotels/Resorts
    Consumer Discretionary

    Melco Resorts Announces Unaudited Fourth Quarter 2025 Earnings

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (NASDAQ:MLCO) ("Melco Resorts" or the "Company"), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Total operating revenues for the fourth quarter of 2025 were US$1.29 billion, representing an increase of approximately 9% from US$1.19 billion for the comparable period in 2024. The increase in total operating revenues was primarily attributable to the improved overall rolling chip and mass market table games performance. Operating income for the fourth quarter of 2025

    2/12/26 7:56:47 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    $AA
    $ABVC
    $AHI
    $AMST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President, Science & Tech. Binder Gwendolyn bought $24,763 worth of shares (11,312 units at $2.19), increasing direct ownership by 57% to 31,312 units (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:30 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Tomasello Shawn bought $50,322 worth of shares (22,725 units at $2.21) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:55:49 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ENTADFI issued to VERU INC

    Submission status for VERU INC's drug ENTADFI (ORIG-1) with active ingredient FINASTERIDE;TADALAFIL has changed to 'Approval' on 12/09/2021. Application Category: NDA, Application Number: 215423, Application Classification: Type 4 - New Combination

    12/13/21 8:12:46 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Tentative Approval for YUTREPIA issued to Liquidia Technologies, Inc.

    Submission status for Liquidia Technologies, Inc.'s drug YUTREPIA (ORIG-1) with active ingredient TREPROSTINIL has changed to 'Tentative Approval' on 11/04/2021. Application Category: NDA, Application Number: 213005, Application Classification: Type 3 - New Dosage Form

    11/18/21 2:49:33 PM ET
    $LQDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP, CAO & Corporate Controller Zhang Rui was granted 1,467 shares, increasing direct ownership by 5% to 33,387 units (SEC Form 4)

    4 - PHOTRONICS INC (0000810136) (Issuer)

    2/11/26 7:50:58 PM ET
    $PLAB
    Semiconductors
    Technology

    Chief Accounting Officer Donnell Paul covered exercise/tax liability with 44 shares, decreasing direct ownership by 0.13% to 34,311 units (SEC Form 4)

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    2/11/26 7:28:40 PM ET
    $NOTE
    Real Estate

    Director Yao Gerald covered exercise/tax liability with 42 shares (SEC Form 4)

    4 - FiscalNote Holdings, Inc. (0001823466) (Issuer)

    2/11/26 7:28:20 PM ET
    $NOTE
    Real Estate

    $AA
    $ABVC
    $AHI
    $AMST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Helmerich & Payne with a new price target

    TD Cowen reiterated coverage of Helmerich & Payne with a rating of Hold and set a new price target of $38.00 from $35.00 previously

    2/9/26 6:46:33 AM ET
    $HP
    Oil & Gas Production
    Energy

    Lake Street initiated coverage on Plus Therapeutics with a new price target

    Lake Street initiated coverage of Plus Therapeutics with a rating of Buy and set a new price target of $2.00

    2/3/26 8:52:26 AM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    Alcoa downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Alcoa from Overweight to Equal-Weight and set a new price target of $64.00

    1/27/26 8:39:42 AM ET
    $AA
    Aluminum
    Industrials

    $AA
    $ABVC
    $AHI
    $AMST
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by American Outdoor Brands Inc.

    SCHEDULE 13G/A - American Outdoor Brands, Inc. (0001808997) (Subject)

    2/12/26 1:42:53 PM ET
    $AOUT
    Recreational Games/Products/Toys
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Xometry Inc.

    SCHEDULE 13G/A - Xometry, Inc. (0001657573) (Subject)

    2/12/26 10:09:00 AM ET
    $XMTR
    Real Estate

    SEC Form 6-K filed by DoubleDown Interactive Co. Ltd.

    6-K - DoubleDown Interactive Co., Ltd. (0001799567) (Filer)

    2/11/26 4:10:15 PM ET
    $DDI
    EDP Services
    Technology

    $AA
    $ABVC
    $AHI
    $AMST
    Leadership Updates

    Live Leadership Updates

    View All

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

    Dr. Mantelli, former Chief Medical Officer at Dompé, spearheaded the successful clinical development program and FDA approval of Oxervate®, a blockbuster orphan therapy in corneal diseaseDr. Mantelli will lead the clinical and regulatory strategy to advance the company's development program in neuropathic corneal pain (NCP), leveraging urcosimod's FDA Fast Track designationThis appointment, following the recent CEO appointment, further strengthens OKYO's world-class ophthalmology leadership team LONDON and NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neur

    2/10/26 8:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Photronics Appoints Jeff Catlin Senior Vice President, Global Sales

    BROOKFIELD, Conn., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today announced the appointment of Jeff Catlin as the company's Senior Vice President, Global Sales. Mr. Catlin will serve as the head of sales for Photronics, driving a unified strategy that will align all sales teams. Mr. Catlin brings more than two decades of leadership experience in the semiconductor industry, including over 10 years of building and managing global sales organizations that deliver measurable growth. Jeff comes to Photronics having held senior roles spanning SVP of Sales & Marketing, Head of Sales Operations, VP/GM of Patterni

    1/8/26 8:00:00 AM ET
    $PLAB
    Semiconductors
    Technology

    Photronics Appoints Michelle Almeida to the Board of Directors

    BROOKFIELD, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, announced today the appointment of Michelle Almeida to the company's Board of Directors effective January 1, 2026. Ms. Almeida will serve as an independent director. "Michelle brings strong leadership experience and a thoughtful, strategic perspective that will complement the skills and experience of our Board," said George Macricostas, Chairman and CEO of Photronics. "We are pleased to welcome her to the Board as we continue to execute our long-term strategy." "I am delighted to join the Photronics Board of Directors," said Ms. Almeida. "I look

    1/7/26 4:15:00 PM ET
    $PLAB
    Semiconductors
    Technology

    $AA
    $ABVC
    $AHI
    $AMST
    Financials

    Live finance-specific insights

    View All

    Melco Resorts Announces Unaudited Fourth Quarter 2025 Earnings

    MACAU, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment Limited (NASDAQ:MLCO) ("Melco Resorts" or the "Company"), a developer, owner, and operator of integrated resort facilities in Asia and Europe, today reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Total operating revenues for the fourth quarter of 2025 were US$1.29 billion, representing an increase of approximately 9% from US$1.19 billion for the comparable period in 2024. The increase in total operating revenues was primarily attributable to the improved overall rolling chip and mass market table games performance. Operating income for the fourth quarter of 2025

    2/12/26 7:56:47 AM ET
    $MLCO
    Hotels/Resorts
    Consumer Discretionary

    DoubleDown Interactive Reports Record Fourth Quarter and Full Year 2025 Financial Results

    SEOUL, Korea, Feb. 11, 2026 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) ("DoubleDown" or the "Company"), a leading developer and publisher of digital games on mobile and web-based platforms, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 vs. Fourth Quarter 2024 Summary: Revenue was $95.8 million in the fourth quarter of 2025 compared to $82.0 million in the fourth quarter of 2024. Revenue from the Company's social casino/free-to-play games was $79.7 million in the fourth quarter of 2025, a 9.3% increase from the fourth quarter of 2024. The 2025 fourth quarter revenue includes the first fu

    2/11/26 4:15:00 PM ET
    $DDI
    EDP Services
    Technology

    Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

    -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m. ET-- MIAMI, FL, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced financial results for its fiscal 2026 first quarter ended December 31, 2025, and provided a corporate update. "The strategy for the next generation of obesity drugs should be a combination therapy with GLP-1 receptor agonists for

    2/11/26 6:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AA
    $ABVC
    $AHI
    $AMST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 3:36:55 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care